The investment will go toward finishing a Phase 2a clinical trial for an anti-infective to treat chronic infections in people with CF.
Barisic will transition from current role as Chief Financial and Administrative Officer in January 2023
|
3 min read
The Cystic Fibrosis Foundation is providing up to $5 million to develop a method to deliver a healthy copy of the CFTR gene into the lung cells of people with CF that is unlikely to trigger an immune system response.
|
4 min read
Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
|
3 min read
CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF
|
3 min read